We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
19 hedge funds and large institutions have $2.98M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% less funds holding
Funds holding: 22 → 19 (-3)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
74% less capital invested
Capital invested by funds: $11.5M → $2.98M (-$8.48M)
Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$14K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.8K |
| 3 |
Bank of New York Mellon
New York
|
+$2.23K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$111 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$111 |
